Medicare Enrolled
Dr. Zoltan Mocsary, M.D.
Neurology · Visalia, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mocsary from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mocsary?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mocsary
Dr. Zoltan Mocsary is a neurology specialist in Visalia, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mocsary performed 10,428 Medicare services across 815 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mocsary received a total of $15,918 from 75 pharmaceutical and/or device companies across 807 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mocsary is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in CA
$15,918 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,428
Medicare services
Top 10% in CA for neurology
815
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~521 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
9,400 | $5 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
272 | $85 | $131 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
236 | $61 | $95 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
153 | $122 | $175 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
96 | $78 | $112 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
51 | $4 | $5 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
47 | $219 | $325 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
44 | $10 | $16 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
42 | $80 | $113 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
39 | $117 | $157 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
17 | $35 | $44 |
| Additional 30 minutes of psychological or neuropsychological testing This code represents an additional 30-minute increment for administering psychological or neuropsychological tests. It is used to bill for time beyond the initial testing period. |
16 | $32 | $40 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $40 | $58 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,918
Total received (2018-2024)
Avg $2,274/year across 7 years
Top 18% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
807
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,876 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$42 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,273
2023
$2,771
2022
$2,210
2021
$2,905
2020
$2,154
2019
$2,088
2018
$1,516
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$376
Novartis Pharmaceuticals Corporation
$281
Neurocrine Biosciences, Inc.
$184
Lilly USA, LLC
$158
Eisai Inc.
$147
ARGENX US, INC.
$114
UCB, Inc.
$104
Sumitomo Pharma America, Inc.
$90
ACADIA Pharmaceuticals Inc
$80
Amneal Pharmaceuticals LLC
$75
PFIZER INC.
$72
Genentech USA, Inc.
$72
Lundbeck LLC
$65
JAZZ PHARMACEUTICALS INC.
$58
Celgene Corporation
$53
Averitas Pharma Inc.
$38
EMD Serono, Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$34
Biogen, Inc.
$31
Neurelis, Inc.
$30
Vanda Pharmaceuticals Inc.
$24
MDD US Operations, LLC
$24
Merz Pharmaceuticals, LLC
$20
Alnylam Pharmaceuticals Inc.
$20
Otsuka America Pharmaceutical, Inc.
$19
Grifols USA, LLC
$19
Mallinckrodt Hospital Products Inc.
$18
Teva Pharmaceuticals USA, Inc.
$16
LivaNova USA, Inc.
$15
Top 3 companies account for 37.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,236
UCB, Inc.
$1,161
Novartis Pharmaceuticals Corporation
$1,021
Biogen, Inc.
$1,013
Supernus Pharmaceuticals, Inc.
$962
Teva Pharmaceuticals USA, Inc.
$857
Kyowa Kirin, Inc.
$612
Eisai Inc.
$560
Neurocrine Biosciences, Inc.
$503
Sunovion Pharmaceuticals Inc.
$496
Lilly USA, LLC
$474
ACADIA Pharmaceuticals Inc
$457
Amgen Inc.
$336
LivaNova USA, Inc.
$335
AbbVie Inc.
$321
Biohaven Pharmaceuticals, Inc.
$320
Allergan, Inc.
$296
Amneal Pharmaceuticals LLC
$291
Genentech USA, Inc.
$270
MDD US Operations, LLC
$264
ARGENX US, INC.
$245
Lundbeck LLC
$236
Avanir Pharmaceuticals, Inc.
$233
Sumitomo Pharma America, Inc.
$215
Celgene Corporation
$209
Biohaven Pharmaceutical Holding Company Ltd.
$207
Neurelis, Inc.
$188
GENZYME CORPORATION
$185
Adamas Pharmaceuticals, Inc.
$168
PFIZER INC.
$164
EISAI INC.
$152
Otsuka Pharmaceutical Development & Commercialization, Inc.
$138
Akcea Therapeutics, Inc.
$126
SK Life Science, Inc.
$100
JAZZ PHARMACEUTICALS INC.
$95
EMD Serono, Inc.
$87
Janssen Pharmaceuticals, Inc
$82
CSL Behring
$81
Horizon Therapeutics plc
$71
AstraZeneca Pharmaceuticals LP
$68
Allergan Inc.
$67
Mallinckrodt Hospital Products Inc.
$60
E.R. Squibb & Sons, L.L.C.
$58
GlaxoSmithKline, LLC.
$57
AQUESTIVE THERAPEUTICS, INC.
$53
Alexion Pharmaceuticals, Inc.
$48
Upsher-Smith Laboratories LLC
$45
Otsuka America Pharmaceutical, Inc.
$44
Acorda Therapeutics, Inc
$42
GE HealthCare
$41
Averitas Pharma Inc.
$38
Zogenix Inc.
$35
GE Healthcare
$34
Takeda Pharmaceuticals U.S.A., Inc.
$34
Boston Scientific Corporation
$32
Kowa Pharmaceuticals America, Inc.
$30
GE HEALTHCARE
$29
Vanda Pharmaceuticals Inc.
$24
Amylyx Pharmaceuticals, Inc.
$24
CATALYST PHARMACEUTICALS, INC.
$23
IDORSIA PHARMACEUTICALS US INC
$22
PROCEPT BioRobotics Corporation
$22
Bayer HealthCare Pharmaceuticals Inc.
$21
SANOFI-AVENTIS U.S. LLC
$21
Merz Pharmaceuticals, LLC
$20
Alnylam Pharmaceuticals Inc.
$20
Cala Health, Inc.
$19
Grifols USA, LLC
$19
Janssen Biotech, Inc.
$16
BANNER LIFE SCIENCES, LLC
$15
Axonics, Inc.
$14
UPSHER-SMITH LABORATORIES LLC
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Assertio Therapeutics, Inc.
$13
OWP Pharmaceuticals, Inc.
$10
Top 3 companies account for 21.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · ANORO · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · AquaBeam Robotic System · Austedo XR · Axonics · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Banzel · Betaseron · Briviact · CALA KIQ · CAMBIA · COMIRNATY · DUOPA · EMGALITY · EPIDIOLEX · Enspryng · Erleada · FIRDAPSE · Fintepla · Fycompa · GENERAL DBS · GENERAL THERAPIES · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LYRICA · Leqembi · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · ONFI · ONPATTRO · OXTELLAR XR · Ocrevus Zunovo · Ongentys · Ozanimod · PLEGRIDY · PONVORY · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · RELYVRIO · REXULTI · RYTARY · Rystiggo · SOLIRIS · SUBVENITE · SUNOSI · SYMPAZAN · Seglentis · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · UPLIZNA · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XADAGO · Xeomin · ZEPOSIA · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
7
Per 100K population
1.5
County median income
$69,489
Nearest hospital
KAWEAH HEALTH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mocsary is a mixed practice specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mocsary experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Mocsary performed 9,400 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mocsary receive payments from pharmaceutical companies?
Yes. Dr. Mocsary received a total of $15,918 from 75 companies across 807 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mocsary's costs compare to other neurologists in Visalia?
Dr. Mocsary's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mocsary) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Visalia
Browse neurologists in Visalia ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology